Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil pharmacogenetic study in elective thyroidectomy
ACTRN12616001598471Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Mar 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil in postoperative pain, sponsored by Aristotle University of Thessaloniki. Started Mar 2017; status: completed.
02
Drugs
remifentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12616001598471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001598471.